
Jerome Jackson Jr.
Examiner (ID: 15347, Phone: (571)272-1730 , Office: P/2815 )
| Most Active Art Unit | 2815 |
| Art Unit(s) | 2503, 2815, 2899, 2811 |
| Total Applications | 2143 |
| Issued Applications | 1551 |
| Pending Applications | 52 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7210669
[patent_doc_number] => 20050053923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Detection of West Nile virus infection and vaccination'
[patent_app_type] => utility
[patent_app_number] => 10/937157
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8221
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053923.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937157 | Detection of West Nile virus infection and vaccination | Sep 8, 2004 | Issued |
Array
(
[id] => 5672459
[patent_doc_number] => 20060177813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Novel high-throughput screening method of drug for bioactive protein'
[patent_app_type] => utility
[patent_app_number] => 10/571081
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12099
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177813.pdf
[firstpage_image] =>[orig_patent_app_number] => 10571081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/571081 | High throughput screening method of drug for physiologically active protein | Sep 7, 2004 | Issued |
Array
(
[id] => 5820016
[patent_doc_number] => 20060024329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Recombinant live vaccine based on canine herpesvirus, in particular against Carre\'s disease, rabies or the parainfluenza virus type 2.'
[patent_app_type] => utility
[patent_app_number] => 10/935494
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6455
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024329.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935494
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935494 | Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2. | Sep 6, 2004 | Abandoned |
Array
(
[id] => 5069542
[patent_doc_number] => 20070190644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Treatment of spinal cord injury'
[patent_app_type] => utility
[patent_app_number] => 10/570402
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9780
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570402
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570402 | Treatment of spinal cord injury | Sep 2, 2004 | Issued |
Array
(
[id] => 876072
[patent_doc_number] => RE040233
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2008-04-08
[patent_title] => 'Viral variants and methods for detecting same'
[patent_app_type] => reissue
[patent_app_number] => 10/920462
[patent_app_country] => US
[patent_app_date] => 2004-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7567
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/040/RE040233.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920462
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920462 | Viral variants and methods for detecting same | Aug 17, 2004 | Issued |
Array
(
[id] => 292072
[patent_doc_number] => 07544361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Hetero type pentamer recombinant vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/565595
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 6494
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544361.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565595
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565595 | Hetero type pentamer recombinant vaccine | Jul 22, 2004 | Issued |
Array
(
[id] => 7208817
[patent_doc_number] => 20050053621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Safe mutant viral vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/893712
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8016
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053621.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893712 | Safe mutant viral vaccines | Jul 15, 2004 | Issued |
Array
(
[id] => 318509
[patent_doc_number] => 07521218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-21
[patent_title] => 'Keratinocyte culturing method and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/564964
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7922
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564964
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564964 | Keratinocyte culturing method and the use thereof | Jul 14, 2004 | Issued |
Array
(
[id] => 7212330
[patent_doc_number] => 20050054107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Alpha virus-based cytomegalovirus vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/886773
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10438
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10886773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/886773 | Alpha virus-based cytomegalovirus vaccines | Jul 7, 2004 | Issued |
Array
(
[id] => 330368
[patent_doc_number] => 07510863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making'
[patent_app_type] => utility
[patent_app_number] => 10/868381
[patent_app_country] => US
[patent_app_date] => 2004-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16128
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/510/07510863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868381 | Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making | Jun 15, 2004 | Issued |
Array
(
[id] => 7317492
[patent_doc_number] => 20040224310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Anti-paratopic antibody as an immunogen'
[patent_app_type] => new
[patent_app_number] => 10/864526
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6984
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224310.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864526 | Anti-paratopic antibody as an immunogen | Jun 9, 2004 | Abandoned |
Array
(
[id] => 363339
[patent_doc_number] => 07482149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Inhibition of SARS coronavirus infection with clinically approved antiviral drugs'
[patent_app_type] => utility
[patent_app_number] => 10/560198
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6496
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/482/07482149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560198 | Inhibition of SARS coronavirus infection with clinically approved antiviral drugs | Jun 8, 2004 | Issued |
Array
(
[id] => 7249410
[patent_doc_number] => 20040258665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith'
[patent_app_type] => new
[patent_app_number] => 10/862036
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8872
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862036 | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith | Jun 3, 2004 | Issued |
Array
(
[id] => 295771
[patent_doc_number] => 07541038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Fusogenic, self-propagating blebs as immunogenic compositions'
[patent_app_type] => utility
[patent_app_number] => 10/559429
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15140
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559429 | Fusogenic, self-propagating blebs as immunogenic compositions | Jun 1, 2004 | Issued |
Array
(
[id] => 7083092
[patent_doc_number] => 20050048472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Active truncated form of the RNA polymerase of flavivirus'
[patent_app_type] => utility
[patent_app_number] => 10/857244
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5650
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048472.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857244 | Active truncated form of the RNA polymerase of flavivirus | May 27, 2004 | Issued |
Array
(
[id] => 7295061
[patent_doc_number] => 20040213807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Use of Parapox B2L protein to modify immune responses to administered antigens'
[patent_app_type] => new
[patent_app_number] => 10/857546
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4129
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20040213807.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857546
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857546 | Use of Parapox B2L protein to modify immune responses to administered antigens | May 27, 2004 | Abandoned |
Array
(
[id] => 102297
[patent_doc_number] => 07723094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/855975
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17992
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855975
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855975 | Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy | May 26, 2004 | Issued |
Array
(
[id] => 558690
[patent_doc_number] => 07470666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-30
[patent_title] => 'Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/558226
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1558
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558226 | Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome | May 24, 2004 | Issued |
Array
(
[id] => 5642268
[patent_doc_number] => 20060280723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Interferon for treating or preventing a coronaviral infection'
[patent_app_type] => utility
[patent_app_number] => 10/557761
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7199
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20060280723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557761 | Interferon for treating or preventing a coronaviral infection | May 18, 2004 | Abandoned |
Array
(
[id] => 7061701
[patent_doc_number] => 20050004063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference'
[patent_app_type] => utility
[patent_app_number] => 10/848737
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20276
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848737 | Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference | May 18, 2004 | Issued |